Success Metrics

Clinical Success Rate
86.2%

Based on 25 completed trials

Completion Rate
86%(25/29)
Active Trials
14(25%)
Results Posted
40%(10 trials)
Terminated
4(7%)

Phase Distribution

Ph not_applicable
18
32%
Ph phase_1
2
4%
Ph phase_3
2
4%
Ph early_phase_1
1
2%
Ph phase_2
10
18%
Ph phase_4
2
4%

Phase Distribution

3

Early Stage

10

Mid Stage

4

Late Stage

Phase Distribution35 total trials
Early Phase 1First-in-human
1(2.9%)
Phase 1Safety & dosage
2(5.7%)
Phase 2Efficacy & side effects
10(28.6%)
Phase 3Large-scale testing
2(5.7%)
Phase 4Post-market surveillance
2(5.7%)
N/ANon-phased studies
18(51.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.6%

25 of 31 finished

Non-Completion Rate

19.4%

6 ended early

Currently Active

14

trials recruiting

Total Trials

57

all time

Status Distribution
Active(17)
Completed(25)
Terminated(6)
Other(9)

Detailed Status

Completed25
Recruiting9
unknown8
Active, not recruiting5
Terminated4
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
57
Active
14
Success Rate
86.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.9%)
Phase 12 (5.7%)
Phase 210 (28.6%)
Phase 32 (5.7%)
Phase 42 (5.7%)
N/A18 (51.4%)

Trials by Status

not_yet_recruiting35%
active_not_recruiting59%
completed2544%
suspended12%
withdrawn24%
recruiting916%
unknown814%
terminated47%

Recent Activity

Clinical Trials (57)

Showing 20 of 57 trialsScroll for more
NCT01920932Phase 2

Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma

Active Not Recruiting
NCT05379153Phase 3

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Recruiting
NCT07320820

Quality of Life and Functional Outcomes in Laryngeal Cancer Patients

Not Yet Recruiting
NCT00280189

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

Suspended
NCT01589302Phase 2

PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia

Active Not Recruiting
NCT04375384Phase 2

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Recruiting
NCT05081999Phase 4

De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease

Active Not Recruiting
NCT04827563

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Terminated
NCT06082804Not Applicable

Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia

Recruiting
NCT07427901Not Applicable

Quality Of Life In Colorectal Cancer Survivors

Recruiting
NCT01473784Not Applicable

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Recruiting
NCT06101706Not Applicable

Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients

Completed
NCT06822348Not Applicable

Short-term Effects of Osteopathic Manipulations on Heart Rate Variability in Lung Cancer Patients - A Randomized Pilot Study

Not Yet Recruiting
NCT01196936Phase 2

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors

Active Not Recruiting
NCT02131805Not Applicable

Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma

Completed
NCT07306468

Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

Recruiting
NCT07262047

Quality of Life Among Children With Inborn Error of Immunity

Not Yet Recruiting
NCT04820036Not Applicable

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Active Not Recruiting
NCT04495751Early Phase 1

Muscadine Grape Extract to Improve Fatigue

Completed
NCT03932786

Studying Health Outcomes After Treatment in Patients With Retinoblastoma

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
57